Join our panel of clinical trial experts as they analyze the election results and explore their potential influence on the future of clinical trials. We’ll discuss key items on the congressional agenda, anticipated changes in policy and funding, and the implications for FDA oversight. Don’t miss this critical conversation on how political shifts could shape the clinical research landscape.
Speakers:
Catherine Gregor, Chief Clinical Trial Officer, Florence Healthcare
Jackie Kent, Executive Advisor, Independent
Sophia McLeod, Sr, Government Relations, ACRO
Casey Orvin, Chief Commercial Officer, Alcanza Clinical
